# E-DRUG: siting of community pharmacies **URL:** \ **Category:** e-drug\ **Created:** [July 19, 1999, 8:03am UTC](https://talk.edrugplus.org/t/e-drug-siting-of-community-pharmacies/5577 "1999-07-19T08:03:30Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Mrs\_Rachel\_Fitzpatri](https://avatars.discourse-cdn.com/v4/letter/m/5fc32e/32.png) [@Mrs\_Rachel\_Fitzpatri](https://talk.edrugplus.org/u/Mrs_Rachel_Fitzpatri)\ **Post date:** [July 19, 1999, 8:03am UTC](https://talk.edrugplus.org/t/e-drug-siting-of-community-pharmacies/5577/1 "1999-07-19T08:03:30Z")
E-drug: siting of community pharmacies --------------------------------------------------------- Request for information Research project: Models that can be used to regulate siting of community pharmacies in South Africa One of the objectives of the South African National Drug Policy (1996) is to ensure the availability and accessibility of safe, good quality, essential drugs for all citizens. Research has, however, shown that there has been a geographical maldistribution of pharmacies in South Africa for many years. Such maldistribution can affect the availability and accessibility of comprehensive pharmaceutical services. One of the ways the South African Pharmacy Council is committed to improving pharmaceutical services in South Africa is, inter alia, by monitoring and addressing the issue of pharmacy maldistribution in the country. The geographical distribution of pharmacies could be improved through the introduction of a siting policy for community pharmacies. In order for such a policy to be effective and in line with the constitutional rights of both pharmacists and the public, the entire issue of siting will have to be thoroughly investigated prior to the drafting and implementation of a policy of this nature. The Council is currently researching this issue. The aim of the research is to develop and evaluate models whereby the geographical distribution of pharmacies can be improved by means of a siting policy. Any information pertaining to the following would be particularly useful and most appreciated: � siting policies currently or previously in place in South Africa and/or other countries (particularly, but not limited to, those relating to pharmacies or other health care facilities); � copies or extracts from applicable regulations/legislation or similar research projects; � contact details of organisations responsible for siting; and � contact details of organisations/persons who have undertaken/are undertaking similar research/studies. Please also forward this request to any organisations/persons that may be able to provide additional information. Thank you, Mrs Rachel Fitzpatrick Professional Affairs: Research South African Pharmacy Council research@pharmcouncil.co.za tel +27-12 - 321-1477 fax +27-12 - 321-1492 P O Box 40040 ARCADIA 0007 SOUTH AFRICA [see also earlier discussion on siting of pharmacies in E-drug. Archives are at: [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html) WB] -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.